Deficiency of CXCR3 alone has been associated with the effective reduction of colitis via reduced monocyte and neutrophil infiltration, ameliorating DSS-induced colitis, thereby making CXCR3 an attractive target for reducing inflammation. This evidence concerns the gene CXCR3 and colitis.